Rakovina Therapeutics Inc. Announces Q1 2023 Financial Results and Provides Corporate Update

VANCOUVER, British Columbia, May 31, 2023 -- Rakovina Therapeutics Inc. , a biopharmaceutical company dedicated to improving the lives of cancer patients through development of novel DNA-damage... | May 31, 2023

Related Keywords

United States ,United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,American ,Jeffrey Bacha ,Summaryfinancial Resultsforthequarterendedmarch ,Drug Administration ,American Association Of Cancer Research ,Rakovina Therapeutics Inc ,Health Canada ,American Association ,Cancer Research ,National Research Council ,Canada Industrial Research Assistance Program ,Rakovina Therapeutics ,Inhibitors Summit ,Financial Resultsforthequarterendedmarch ,United States Food ,Rakovina Therapeutics Inc Stock Exchange ,News ,Information ,Press Release ,Bay ,023 ,Rakovina ,Herapeutics ,Iopharmaceutical ,Company ,Edicated ,O ,Improving ,The ,Lives ,F ,Dancer ,Patients ,Through ,Development ,Ovel Rkv Ca75103l1013 ,